comparemela.com

Latest Breaking News On - 10113710 - Page 2 : comparemela.com

9,357 Shares in Boston Scientific Co (NYSE:BSX) Bought by Eagle Wealth Strategies LLC

Eagle Wealth Strategies LLC acquired a new position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 9,357 shares of the medical equipment provider’s stock, valued at approximately $541,000. Other hedge funds and other institutional […]

Boston Scientific (NYSE:BSX) Price Target Raised to $82 00

Boston Scientific (NYSE:BSX – Free Report) had its price target increased by Needham & Company LLC from $71.00 to $82.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock. Several other brokerages have also weighed in on BSX. BTIG Research reaffirmed […]

Boston Scientific Co (NYSE:BSX) Shares Sold by Private Wealth Partners LLC

Private Wealth Partners LLC trimmed its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 0.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 233,364 shares of the medical equipment provider’s stock after selling 415 shares during the period. Boston Scientific accounts for approximately 1.1% of Private Wealth Partners LLC’s […]

Boston Scientific (NYSE:BSX) Given New $78 00 Price Target at Barclays

Boston Scientific (NYSE:BSX – Free Report) had its price objective lifted by Barclays from $70.00 to $78.00 in a report published on Friday morning, Benzinga reports. Barclays currently has an overweight rating on the medical equipment provider’s stock. A number of other research firms have also weighed in on BSX. Citigroup increased their price objective […]

Boston Scientific (NYSE:BSX) Updates FY 2024 Earnings Guidance

Boston Scientific (NYSE:BSX – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 2.290-2.340 for the period, compared to the consensus EPS estimate of 2.250. The company issued revenue guidance of $15.8 billion-$16.1 billion, compared to the consensus revenue estimate of $15.6 billion. Boston Scientific also updated […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.